Medications

VESIcare LS approved for neurogenic detrusor overactivity

VESIcare LS (solifenacin succinate) oral suspension is now approved to treat neurogenic detrusor overactivity (NDO) in children 2 years and older, the U.S. Food and Drug Administration announced Tuesday.

Medical research

New research takes p*** out of incontinence

Millions of people might eventually be spared the embarrassment and extreme isolation caused by wetting themselves, thanks to new research.

Psychology & Psychiatry

Behavioral therapy first step for overactive bladder in men

Among men with overactive bladder, combined behavioral and drug therapy is superior to drug therapy alone, but not behavioral therapy alone, for symptomatic improvement, according to a study published online Jan. 13 in JAMA ...

Medications

Bladder drug linked to atherosclerosis in mice

A drug used in the treatment of overactive bladder can accelerate atherosclerosis in mice, researchers at Karolinska Institutet in Sweden report in a study published in the Proceedings of the National Academy of Sciences ...

Pediatrics

Pediatric researchers offer solutions to bedwetting by children

If you're up in the middle of the night putting your child's soaked-through bed sheets and pajamas into the washing machine again, you might be wondering how long until you don't have to do this anymore. For most children, ...

page 1 from 6